The last time GEN compiled a list of CEOs, investors, and others with the biggest stakes in biopharma companies—what GEN calls “molecular millionaires”—was last year, based on 2016 data. Only one new person who had not been listed in previous editions made the cut back then.
{iframe}https://www.genengnews.com/lists/top-10-molecular-millionaires-of-2018/?utm_medium=newsletter&utm_source=GEN%20Daily%20News%20Highlights&utm_content=01&utm_campaign=GEN%20Daily%20News%20Highlights_20181214&ajs_uid=5901D8426578G1Y&oly_enc_id=5901D8426578G1Y&ajs_trait_oebid=9675B9130356B7S{/iframe}